Neurogene Inc.
Pharmaceutical Preparations · New York, NY, United States
- PrincipalsChristine Mikail CvijicPresident and CFOJulie JordanChief Medical OfficerRachel McMinnChief Executive Officerand 6 more
- CompanyNeurogene Inc.New York, NY, United States
- Phone line+1 (877) 237-5020General business
Neurogene Inc. is an SEC-registered Nasdaq-listed company (ticker NGNE) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 9
Chair & board
Cory S. FreedlandDirector (Board)
Keith WoodsDirector (Board)
Robert BaffiDirector (Board)
Rohan PalekarDirector (Board)
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Julie Jordan — Chief Medical Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Rachel McMinn — Chief Executive Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Christine Mikail Cvijic — President and CFO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Stuart Cobb — Chief Scientific Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
enGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityInMed Pharmaceuticals Inc.Pharmaceutical Preparations · Vancouver1 shared capabilityIncannex Healthcare Inc.Pharmaceutical Preparations · Norwest Nsw1 shared capabilityQuantum Cyber N.V.Pharmaceutical Preparations · Mainz1 shared capabilityAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capability